🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 20 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 26/02/2015 | 158,39 | 158,89 | 153,62 | 155,58 | -1,48% | 3,33% | 712.900 |
| 25/02/2015 | 156,14 | 164,38 | 152,44 | 157,92 | +1,78% | 7,65% | 1.061.800 |
| 24/02/2015 | 157,37 | 157,37 | 148,04 | 155,16 | +0,52% | 5,93% | 1.103.600 |
| 23/02/2015 | 157,01 | 160,39 | 151,91 | 154,35 | -1,06% | 5,40% | 988.100 |
| 20/02/2015 | 155,85 | 156,98 | 154,59 | 156,01 | +0,19% | 1,53% | 419.100 |
| 19/02/2015 | 155,79 | 157,06 | 154,25 | 155,72 | +0,08% | 1,80% | 359.000 |
| 18/02/2015 | 155,62 | 156,38 | 153,65 | 155,60 | +0,30% | 1,75% | 331.400 |
| 17/02/2015 | 150,49 | 155,44 | 149,22 | 155,14 | +2,67% | 4,13% | 675.000 |
| 13/02/2015 | 148,08 | 151,25 | 146,02 | 151,11 | +2,43% | 3,53% | 469.800 |
| 12/02/2015 | 146,59 | 147,88 | 144,60 | 147,52 | +0,48% | 2,24% | 357.000 |
| 11/02/2015 | 146,12 | 149,42 | 145,55 | 146,82 | +0,10% | 2,65% | 290.900 |
| 10/02/2015 | 143,29 | 147,46 | 142,20 | 146,68 | +2,86% | 3,67% | 512.300 |
| 09/02/2015 | 141,58 | 144,55 | 140,57 | 142,60 | +0,49% | 2,81% | 450.300 |
| 06/02/2015 | 141,82 | 144,50 | 141,22 | 141,91 | -0,01% | 2,31% | 329.400 |
| 05/02/2015 | 140,25 | 143,00 | 140,15 | 141,92 | +0,97% | 2,03% | 258.700 |
| 04/02/2015 | 140,34 | 141,77 | 137,67 | 140,55 | -1,01% | 2,92% | 357.400 |
| 03/02/2015 | 142,19 | 143,77 | 137,87 | 141,99 | +0,02% | 4,15% | 388.000 |
| 02/02/2015 | 141,98 | 144,17 | 138,32 | 141,96 | +0,59% | 4,12% | 491.400 |
| 30/01/2015 | 141,79 | 144,27 | 140,15 | 141,13 | -1,01% | 2,91% | 581.900 |
| 29/01/2015 | 144,66 | 145,47 | 142,09 | 142,57 | -1,07% | 2,34% | 510.600 |
| 28/01/2015 | 148,06 | 148,68 | 143,76 | 144,11 | -2,09% | 3,32% | 594.000 |
| 27/01/2015 | 145,36 | 148,80 | 145,36 | 147,19 | +0,50% | 2,37% | 270.400 |
| 26/01/2015 | 144,70 | 147,25 | 143,35 | 146,46 | +0,80% | 2,70% | 422.900 |
| 23/01/2015 | 147,39 | 148,97 | 144,81 | 145,30 | -1,43% | 2,82% | 396.600 |
| 22/01/2015 | 146,97 | 148,44 | 143,54 | 147,41 | +0,48% | 3,33% | 543.000 |
| 21/01/2015 | 145,65 | 149,02 | 145,26 | 146,70 | +0,15% | 2,58% | 641.800 |
| 20/01/2015 | 141,78 | 148,19 | 140,93 | 146,48 | +3,82% | 5,12% | 876.100 |
| 16/01/2015 | 137,80 | 141,31 | 137,40 | 141,09 | +2,36% | 2,84% | 776.100 |
| 15/01/2015 | 136,00 | 139,24 | 135,54 | 137,84 | +1,46% | 2,72% | 743.300 |
| 14/01/2015 | 133,92 | 136,21 | 133,34 | 135,85 | +0,85% | 2,14% | 718.800 |